Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.22 - $0.46 $2,870 - $6,002
13,049 Added 66.05%
32,805 $7,000
Q1 2023

May 09, 2023

SELL
$0.31 - $0.77 $2,319 - $5,761
-7,483 Reduced 27.47%
19,756 $9,000
Q4 2022

Feb 10, 2023

BUY
$0.16 - $1.1 $2,658 - $18,279
16,618 Added 156.46%
27,239 $9,000
Q3 2022

Nov 10, 2022

SELL
$1.62 - $2.73 $10,421 - $17,562
-6,433 Reduced 37.72%
10,621 $18,000
Q2 2022

Aug 15, 2022

BUY
$1.41 - $2.77 $21,412 - $42,065
15,186 Added 812.96%
17,054 $35,000
Q1 2022

May 12, 2022

SELL
$1.58 - $2.82 $2,755 - $4,918
-1,744 Reduced 48.28%
1,868 $5,000
Q4 2021

Feb 14, 2022

BUY
$2.06 - $3.61 $5,601 - $9,815
2,719 Added 304.48%
3,612 $8,000
Q3 2021

Nov 15, 2021

BUY
$2.98 - $4.31 $2,661 - $3,848
893 New
893 $3,000
Q2 2021

Aug 16, 2021

SELL
$3.08 - $5.13 $10,970 - $18,273
-3,562 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$4.55 - $6.72 $4,677 - $6,908
-1,028 Reduced 22.4%
3,562 $17,000
Q4 2020

Feb 16, 2021

SELL
$4.24 - $5.97 $30,896 - $43,503
-7,287 Reduced 61.35%
4,590 $23,000
Q3 2020

Nov 16, 2020

BUY
$4.12 - $5.91 $40,511 - $58,113
9,833 Added 481.07%
11,877 $55,000
Q2 2020

Aug 13, 2020

BUY
$2.94 - $7.7 $6,009 - $15,738
2,044 New
2,044 $11,000
Q4 2019

Feb 07, 2020

SELL
$3.08 - $5.9 $6,914 - $13,245
-2,245 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$5.25 - $9.26 $56,589 - $99,813
-10,779 Reduced 82.76%
2,245 $13,000
Q2 2019

Aug 13, 2019

BUY
$8.51 - $14.95 $110,834 - $194,708
13,024 New
13,024 $122,000

Others Institutions Holding AXLA

About Axcella Health Inc.


  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.